1/3
Looks like no tags are added yet.
Diabetes, using C-peptide detection to help distinguish Type 1 from Type 2 diabetes in simulated patient samples.
What disease are we detecting?
The order of addition is:
1. Capture antibody: Attaches to the plastic well.
2. Patient sample or control: Any C-peptide (antigen) present binds to the capture antibody.
3. HRP-linked detection antibody: Binds to another site on C-peptide, forming a sandwich. This reagent contains both the antibody and its attached HRP enzyme.
4. Substrate solution: Added separately; contains hydrogen peroxide and amino salicylate. HRP catalyzes color development.
PBS washes after the first three steps remove unbound material.
What is the order of biomolecules in the wells?
-, +, P1, P2, P3
Here is the schematic of the ELISA Plate. What is the label order?

C-peptide, a peptide released when proinsulin is processed into insulin. It indicates the body’s own insulin production.
In the protocol’s simplified model, Type 1 diabetes produces undetectable C-peptide, while Type 2 diabetes retains detectable C-peptide.
What biomolecule are we actually detecting?